Navigation Links
Exercise improves thinking, reduces diabetes risk in overweight children
Date:10/22/2007

Just three months of daily, vigorous physical activity in overweight children improves their thinking and reduces their diabetes risk, researchers say.

Studies of about 200 overweight, inactive children ages 7-11 also showed that a regular exercise program reduces body fat and improves bone density.

Is exercise a magic wand that turns them into lean, healthy kids? No. They are still overweight but less so, with less fat, a healthier metabolism and an improved ability to handle life, says Dr. Catherine Davis, clinical health psychologist at the Medical College of Georgia and lead investigator.

All study participants learned about healthy nutrition and the benefits of physical activity; one-third also exercised 20 minutes after school and another third exercised for 40 minutes. Children played hard, with running games, hula hoops and jump ropes, raising their heart rates to 79 percent of maximum, which is considered vigorous.

Aerobic exercise training showed dose-response benefits on executive function (decision-making) and possibly math achievement, in overweight children, researchers write in an abstract being presented during The Obesity Societys Annual Scientific Meeting Oct. 20-24 in New Orleans. Regular exercise may be a simple, important method of enhancing childrens cognitive and academic development. These results may persuade educators to implement vigorous physical activity curricula during a childhood obesity epidemic.

Functional magnetic resonance imaging studies, which show the brain at work, were performed on a percentage of children in each group and found those who exercised had different patterns of brain activity during an executive function task.

Look what good it does when they exercise, says Dr. Davis. This is an important public health issue we need to look at as a nation to help our children learn and keep them well.

Unprecedented obesity and inactivity rates in America
'/>"/>

Contact: Toni Baker
tbaker@mcg.edu
706-721-4421
Medical College of Georgia
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Vascular structure and function improve with diet and exercise
2. Exercise training in ordinary people affects the activity of 500 genes
3. Exercise pill switches on gene that tells cells to burn fat
4. Exercise aside, genes may ultimately dictate seniors mobility
5. Viagra improves high altitude exercise performance up to 45% for some
6. Walking not enough for significant exercise benefits
7. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
8. Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer
9. Product improves peptide identification for proteomics research
10. Stem cell treatment improves mobility after spinal cord injury
11. Combination therapy improves AIDS-related lymphoma outcome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... , March 5, 2015 In Brazil ... of companies already using these solutions and 42 percent planning ... the latter, approximately 25 percent of the companies will be ... While the majority of companies in the region are currently ... the hybrid model will command significant attention in the coming ...
(Date:3/3/2015)... LAKE FOREST, Calif. , March 3, ... ("Company"), the leading provider of advanced cryogenic ... serving markets including immunotherapies, stem cells, cell ... health, and reproductive medicine, today announced the ... Hutchinson Cancer Research Centers, ("Fred Hutch") ...
(Date:3/2/2015)... Ala. , March 2, 2015  Businesses ... processing. Data protection company Tharon Rankins Enterprises has ... that provides an ultra-safe way for businesses to ... their financial transactions. Beconux is ... Tharon Rankins Enterprises. Functioning similarly to an ATM ...
Breaking Biology News(10 mins):Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 4Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3Personal Data Protection Company Launches New Product 2
... detection is critical for improving cancer survival rates. Yet, ... lung cancer, is notoriously difficult to detect in its ... to detect lung cancer by merely shining diffuse light ... new clinical study, the analysis technique--called partial wave spectroscopic ...
... Many scientists aspire to take control over the stem cell ... perfectly matched to each patient in the future. Now research ... SAGE-Hindawi, explains how engineering the topography on which stem cells ... as powerful an agent for change as their chemical environment. ...
... BOZEMAN, Mont. -- Invasive plants make life tougher for ... of the Missouri River Basin, so why not turn the ... time? Russian olive and saltcedar alone could supply biomass ... region. Converting invasive plants to fuel is an ...
Cached Biology News:Cheek swab may detect lung cancer 2Cheek swab may detect lung cancer 3Stem cells shape up to their surroundings 2Stem cells shape up to their surroundings 3Montana State, partners in 6 states consider converting invasive plants to fuel 2Montana State, partners in 6 states consider converting invasive plants to fuel 3Montana State, partners in 6 states consider converting invasive plants to fuel 4
(Date:3/25/2015)... Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; OTCQX: ... with certain shareholders representing approximately 45% of the outstanding ... certain matters including the appointment of auditors at its ... 2015 (the "Meeting") it intends to adjourn the Meeting ... when the Meeting reconvenes. The Meeting will be reconvened ...
(Date:3/25/2015)... , March 25, 2015  S&P Capital IQ ... Factual Stock Report coverage on Abattis Bioceuticals Corp ... CSE: ATT): is a specialty biotechnology company with ... licensing and marketing proprietary ingredients, bio-similar compounds, patented ... North America . The company ...
(Date:3/25/2015)... SHANGHAI , CAMBRIDGE, Mass. and ... -- WuXi NextCODE, which provides comprehensive capabilities for using the ... deCODE genetics on their publication of the largest studies of ... published today online in Nature Genetics ... date of sequence variation, authored by a team of deCODE ...
(Date:3/25/2015)... San Francisco, CA (PRWEB) March 25, 2015 ... Provide Support for Novel Mechanism of Action in ... March 25, 2015 – Cytokinetics, Incorporated (Nasdaq: CYTK) ... its fast skeletal muscle troponin activator tirasemtiv in ... from a Phase IIa “Evidence of Effect” or ...
Breaking Biology Technology:SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 2SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 3SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 4SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 5S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 5Landmark deCODE Studies Demonstrate the Power of Truly Big Genomics for Improving Medicine Worldwide 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 3Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 4Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 5Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 6
... , , ... , , , ... example protein arrays) or as biopharmaceutical therapeutics. In,all cases the ... key quality criteria include: protein identification,quantitation and the monitoring of ...
... , ... , , , When working ... transfection of small interfering RNA (siRNA),into a cell, the presence of having ... be of great value.,Three to four siRNA sequences are generally tested for ...
... , , ... , , This Application Note ... can be used to detect cell surface,and intracellular protein targets by ... on CCRF-CEM cells and intracellular,glucocorticoid receptor (GR) staining of H4 rat ...
Cached Biology Technology:Quality control of antibodies using the,2100 bioanalyzer and the Protein 200,Plus assay 2Quality control of antibodies using the,2100 bioanalyzer and the Protein 200,Plus assay 3siRNA transfection optimization,with the Agilent 2100 bioanalyzer 2siRNA transfection optimization,with the Agilent 2100 bioanalyzer 3siRNA transfection optimization,with the Agilent 2100 bioanalyzer 4siRNA transfection optimization,with the Agilent 2100 bioanalyzer 5siRNA transfection optimization,with the Agilent 2100 bioanalyzer 6siRNA transfection optimization,with the Agilent 2100 bioanalyzer 7Detection of antibody-stained cell,surface and intracellular protein targets,with the Agilent 2100 bioanalyzer 2Detection of antibody-stained cell,surface and intracellular protein targets,with the Agilent 2100 bioanalyzer 3Detection of antibody-stained cell,surface and intracellular protein targets,with the Agilent 2100 bioanalyzer 4Detection of antibody-stained cell,surface and intracellular protein targets,with the Agilent 2100 bioanalyzer 5Detection of antibody-stained cell,surface and intracellular protein targets,with the Agilent 2100 bioanalyzer 6Detection of antibody-stained cell,surface and intracellular protein targets,with the Agilent 2100 bioanalyzer 7Detection of antibody-stained cell,surface and intracellular protein targets,with the Agilent 2100 bioanalyzer 8
... whose sequence corresponds to residues 1-18 from rat rab 3D. ... - A - S - A - S - E - ... - D - A - A - D - Q - ... control experiments with the polyclonal antibody that reacts with this product ...
Rabbit polyclonal antibody to Glutathione-S-Transferase (GST)...
... Assay Kit contains all reagents necessary to ... lineage, as determined by staining for mineralization. ... necessary reagents and a protocol for quantifying ... product is useful for studying the effects ...
... discovery races ever faster, you need a partner ... So our constant focus is on providing tools ... why our Biomek 3000 Laboratory Automation Workstation offers ... it is flexible. By integrating all aspects of ...
Biology Products: